Latest news and insights on the pharmaceutical industry | Indian Pharma Post

Results For "fanregratinib"

1 News Found

HUTCHMED’s Fanregratinib gains priority review in China for aggressive liver cancer
News | January 01, 2026

HUTCHMED’s Fanregratinib gains priority review in China for aggressive liver cancer

ICC is a highly aggressive liver cancer arising from the intrahepatic biliary epithelium